hsa-miR-150 |
SK-OV-3, SNU-119 |
|
|
PI3K-Akt signaling pathway |
Decreased expression of miRNA-150 enhances pertuzumab resistance in ovarian cancer cells through AKT activation. |
Wuerkenbieke et al., 2015 |
hsa-miR-106b |
OVCAR-3 |
Down |
RHOC |
RhoC pathway |
MicroRNA-106b suppresses tumorigenesis and progression of epithelial ovarian cancer by down-regulating the expression of RhoC. |
Chen et al., 2015 |
hsa-miR-17 |
Ovary |
|
LKB1 |
p53 signaling pathway |
hsa-miR-17 regulates proliferation and invasion of ovarian tumor cells via targeting LKB1-p53-p21/WAF1 pathway. |
Liu et al., 2015 |
hsa-miR-224 |
HO-8910, HO8910PM |
Up |
KLLN |
KLLN-cyclin A pathway |
Overexpression of microRNA-224 induces proliferation of ovarian cancer cells by down-regulating KLLN expression. |
Hu et al., 2016 |
hsa-miR-203 |
IOSE-80, IOSE-144, OVCA429, OVCA433 |
Up |
PDHB |
Glycolysis pathway |
MicroRNA-203 functions as an ocogene in ovarian cancer by inducing glycolysis. |
Xiaohong et al., 2016 |
hsa-miR-23a |
OVCA3, SK-OV-3 |
Up |
ST7 |
MAPK signaling pathway |
MicroRNA-23a suppresses proliferation, migration and invasion of epithelial ovarian cancer cells by down-regulating ST7 expression. |
Yang et al., 2016 |
hsa-miR-133b |
SK-OV-3, OVCAR3, HO-8910 |
Up |
EGFR |
PI3K-Akt signaling pathway |
Upregulation of miR-133b suppresses proliferation and invasion of ovarian cancer cells through inhibition PI3K-Akt signaling pathways by down-regulating EGFR expression. |
Liu et al., 2015 |
hsa-miR-634 |
A2780 |
Down |
ERK2 |
RAS signaling pathway |
MicroRNA-634 regains drug sensitivity in resistant ovarian cancer cells by down-regulating the RAS signaling pathway. |
Jaarsveld et al., 2015 |
hsa-miR-1207 |
A2780, SK-OV-3, COV362 |
Up |
SFRP1 |
Wnt signaling pathway |
MicroRNA-1207 plays an important role in regulating the cancer stem cell-like phenotype through targeting SFRP1 by activating the Wnt signaling pathway in ovarian cancer. |
Wu et al., 2015 |
hsa-miR-1207 |
A2780, SK-OV-3, COV362 |
Up |
AXIN2 |
Wnt signaling pathway |
MicroRNA-1207 plays an important role in regulating the cancer stem cell-like phenotype through targeting AXIN2 by activating the Wnt signaling pathway in ovarian cancer. |
Wu et al., 2015 |
hsa-miR-1207 |
A2780, SK-OV-3, COV362 |
Up |
ICAT |
Wnt signaling pathway |
MicroRNA-1207 plays an important role in regulating the cancer stem cell-like phenotype through targeting ICAT by activating the Wnt signaling pathway in ovarian cancer. |
Wu et al., 2015 |
hsa-miR-140 |
A2780, SK-OV-3, OVCAR |
Down |
PDGFRA |
miR-140-5p-PDGFRA pathway |
Upregulation of miR-140 significantly suppresses ovarian cancer cell proliferation and promotes apoptosis by targeting PDGFRA. |
Lan et al., 2015 |
hsa-miR-661 |
A2780, SK-OV-3, OVCAR |
Up |
INPP5J |
PI3K-Akt signaling pathway |
MicroRNA-661 functions as tumor promoter in ovarian cancer cells by down-regulates INPP5J expession. |
Zhu et al., 2015 |
hsa-miR-150 |
SK-OV-3, SNU-119 |
Down |
|
PI3K-Akt signaling pathway |
Decreased expression of miRNA-150 regulates the pertuzumab resistance in ovarian cancer through PI3K-Akt signaling pathway. |
Wuerkenbieke et al., 2015 |
hsa-miR-939 |
A2780, SK-OV-3, Caov-3 |
Up |
APC2 |
Wnt signaling pathway |
MicroRNA-939 acts as a potential tumor promoter by regulating the Wnt signaling pathway through inhibition of APC2 expression. |
Ying et al., 2015 |
hsa-miR-129 |
A2780, SK-OV-3, OVCAR, Caov-3 |
|
YAP |
Hippo signaling pathway |
MicroRNA-129 suppresses ovarian cancer cell proliferation, survival and tumorigenicity by down-regulating YAP expression. |
Tan et al., 2015 |
hsa-miR-197 |
Ovary |
Up |
NLK |
Wnt signaling pathway |
MicroRNA-197 promotes Taxol resistance in human ovarian cancer cells by down-regulating NLK expression. |
Zou et al., 2015 |
hsa-miR-302b |
SK-OV-3, OVCAR3 |
Down |
RUNX1 |
Jak-STAT signaling pathway |
MicroRNA-302b acts as a tumor suppressor in epithelial ovarian cancer by down-regulating RUNX1 expression and regulating the Jak-STAT signaling pathway. |
Ge et al., 2014 |
hsa-miR-7 |
Ovary |
Down |
EGFR |
PI3K-Akt signaling pathway |
MicroRNA-7 suppresses tumor metastasis via PI3K-Akt signaling pathway inactivation by inhibiting EGFR expression in epithelial ovarian cancer. |
Zhou et al., 2014 |
hsa-miR-7 |
Ovary |
Down |
EGFR |
ERK pathway |
MicroRNA-7 suppresses tumor metastasis via ERK1/2 pathway inactivation by inhibiting EGFR expression in epithelial ovarian cancer. |
Zhou et al., 2014 |
hsa-miR-98 |
Ovary |
|
EZH2 |
E2F Signaling pathway |
MicroRNA-98 suppresses cell proliferation in human ovarian cancer stem cells through regulating the Rb/E2F pathway. |
Liu et al., 2014 |
hsa-miR-9 |
SK-OV-3, OVCAR3, Caov-3 |
Down |
TLN1 |
PI3K-Akt signaling pathway |
MicroRNA-9 acts as a tumor suppressor in ovarian serous carcinoma by down-regulating TLN1 expression. |
Tang et al., 2014 |
hsa-miR-141 |
A2780 |
|
KEAP1 |
NF-Kappa B signaling pathway |
MicroRNA-141 down-regulates KEAP1 expression, and decreased expression of KEAP1 promotes cisplatin resistance in ovarian cancer. |
Jaarsveld et al., 2013 |